Estimation of virological and immunological parameters in subjects from South India infected with human immunodeficiency virus type 1 clade C and correlation of findings with occurrence of neurological disease

References

• Anderson M, Hagberg L, , et al 2001. Increased blood-brain barrier permeability in neuroasymptomatic HIV-1 infected individuals—correlation with CSF HIV-1 RNA levels and neopterin levels. J NeuroVirol 7: 542–547.
   Google Scholar
• Ashton L, Carr A, , et al 1998. Predictors of progression in long term non progressors. AIDS Res Human Retroviruses 14: 117–121.
   Google Scholar
• Brew J, Bhalla R, , et al 1990. Cerebrospinal fluid neopterin in HIV-1 infection. Ann Neurol 28: 556–560.
   PubMed Web of Science ®Google Scholar
• Brew J, Dunbar N, , et al 1996. Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of beta 2 microglobulin and neopterin. J Infect Dis 174: 294–298.
   PubMed Web of Science ®Google Scholar
• Christo P, Greco D, , et al 2005. HIV-1 RNA levels in cerebrospinal fluid and their correlation with opportunistic neurological diseases in a Brazilian AIDS Reference Hospital. Arq Neuropsiquiatr 63: 907–913.
   Google Scholar
• Ellis R, Gamst A, , et al 2000. Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology 54: 927–936.
   PubMed Web of Science ®Google Scholar
• Ellovaara I. HIV-1 infection of the brain: which pathogenic mechanisms are relevant for tissue damage?. Rev Med Virol 1995; 5: 105–119
   Google Scholar
• Epstein L, Gendelman H, 1997. HIV-1 neuropathogenesis. In: AIDS and the nervous system, second edition. Berger JR, et al, Levy RM Philadelphia: Lippincott- Raven, pp 59–71.
   Google Scholar
• Fahey J, Taylor J, , et al 1998. Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements. AIDS 12: 1581–1590.
   PubMed Web of Science ®Google Scholar
• Fahey J, Taylor J, , et al 1990. The prognostic value of cellular and serologic markers in infection with Human immunodeficiency virus. N Engl J Med 322: 166–172.
   PubMed Web of Science ®Google Scholar
• Foudraine N, Hoetelmans R, , et al 1998. Cerebrospinal fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine. Lancet 351: 1547–15451.
   PubMed Web of Science ®Google Scholar
• Fuchs D, Chiodi F, , et al 1989. Neopterin concentrations in CSF and serum of individuals infected with HIV-1. AIDS 3: 285–288.
   PubMed Web of Science ®Google Scholar
• Gallo P, Fred K, , et al 1989. HIV-1 infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J Neuroimmunol 23: 109–116.
   PubMed Web of Science ®Google Scholar
• Ghate M, Mehendale S, et al. Relationship between clinical conditions and CD4 counts in HIV infected persons in Pune, Maharashtra, India. Natl Med J India 2000; 13: 183–187
   PubMed Web of Science ®Google Scholar
• Gisslen M, Hagberg L, et al. CSF fluid viral load in HIV-1 infected patients without antiretroviral treatment: a longitudinal study. J AIDS Hum Retroviruses 1998; 17: 291–295
   Google Scholar
• Griffin D, McArthur J, et al. Neopterin and interferon gamma in serum and cerebrospinal fluid of patients with HIV associated neurologic disease. Neurology 1991; 41: 69–74
   PubMed Web of Science ®Google Scholar
• Grimaldi M, Martino V, et al. Elevated alpha tumor necrosis factor levels in spinal fluid from HIV-1 infected patients with central nervous system involvement. Ann Neurol 1991; 29: 21–25
   PubMed Web of Science ®Google Scholar
• Godfried M, Poll T, et al. Soluble receptors for Tumor necrosis factor as predictors of progression to AIDS in asymptomatic HIV-1 infection. J Infect Dis 1994; 169: 739–745
   PubMed Web of Science ®Google Scholar
• Kamat A, Ravi V, et al. Quantitation of HIV-1 RNA levels in plasma and CSF of asymptomatic HIV-1 infected patients from South India using a TaqMan real time PCR assay. J Clin Virol 2007; 39: 9–15
   Google Scholar
• Laurenzi A, Siden A, et al. Cerebrospinal IL-6 activity in HIV infection and inflammatory and noninflammatory diseases of the nervous system. Clin Immunol Immunopathol 1990; 57: 233–241
   PubMedGoogle Scholar
• Lifson R, Hessol A, et al. Serum β2 microglobulin and prediction to progression to AIDS in HIV infection. Lancet 1992; 339: 1436–1440
   PubMed Web of Science ®Google Scholar
• Mahadevan A, Shankar SK, et al. Characterization of human immunodeficiency virus (HIV)-infected cells in infiltrates associated with CNS opportunistic infections in patients with HIV clade C infection. J Neuropathol Exp Neurol 2007; 66: 799–808
   Google Scholar
• McArthur J, McClernon D, et al. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann Neurol 1997; 42: 689–698
   PubMed Web of Science ®Google Scholar
• McArthur J, Nance-Sproson T, et al. The diagnostic utility of elevation in cerebrospinal fluid beta 2 microglobulin in HIV-1 dementia. Neurology 1992; 42: 1707–1712
   PubMed Web of Science ®Google Scholar
• Mellors J, Munoz A, et al. Plasma viral load and CD4 Lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126: 946–954
   PubMed Web of Science ®Google Scholar
• Mellors J, Rinaldo C, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272: 1167–1170
   PubMed Web of Science ®Google Scholar
• Perrella O, Carrieri B, et al. Cerebrospinal fluid beta-2-microglobulin in HIV-1 infection, as a marker of neurological involvement. Neurol Research 1991; 13: 131–132
   PubMedGoogle Scholar
• Perrella O, Cannerri B, et al. Cerebrospinal fluid cytokines in AIDS dementia complex. J Neurol 1992a; 239: 387–388
   PubMed Web of Science ®Google Scholar
• Perrella O, Guirnierro M, et al. IL-6 and granulocyte macrophage CSF in the cerebrospinal fluid from HIV infected subjects with involvement of central nervous system. Arq Neuropsiquiatr 1992b; 50: 180–182
   Google Scholar
• Ramalingam S, Kannangai R, et al. Subtype and cytokine profiles of HIV infected individuals from south India. Indian J Med Res 2005; 121: 226–234
   Google Scholar
• Reddy M, Grieco M. Neopterin and Interleukin-1 levels in sera of patients with Human immunodeficiency virus infection. J Clin Microbiol 1989; 27: 1919–1923
   Google Scholar
• Santosh V, Shankar SK, et al. Pathological lesions in HIV positive patients. Indian J Med Res 1995; 101: 134–141
   PubMed Web of Science ®Google Scholar
• Satishchandra P, Nalini A, et al. Profile of neurologic disorders associated with HIV/AIDS from Bangalore, South India (1989–1996). Indian J Med Res 2000; 111: 14–23
   PubMed Web of Science ®Google Scholar
• Sehgal S, Datta U, et al. Cellular and serological markers of disease activity in Indian patients with HIV/AIDS. Methods Cell Sci 2002; 24: 107–14
   Google Scholar
• Shankar SK, Satishchandra P, et al. Low prevalence of progressive multifocal leukoencephalopathy in India and Africa: is there a biological explanation?. J NeuroVirol 2003; 9: 59–63
   Google Scholar
• Sonnerborg B, Von Stedingk V, et al. Elevated neopterin and β2 microglobulin levels in blood and CSF occur early in HIV infection. AIDS 1989; 3: 277–283
   PubMed Web of Science ®Google Scholar
• Siddappa B, Dash P, et al. Identification of subtype C HIV-1 by subtype specific PCR and its use in the characterization of viruses circulating in the southern parts of India. J Clin Microbiol 2004; 42: 2742–2751
   Google Scholar
• Tyor W, Glass J, et al. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol, , 349 1992; 31: 360
   Google Scholar
• Wadia S, Pujari S, et al. Neurological manifestation of HIV disease. J Ass Phys India 2001; 49: 343–348
   PubMedGoogle Scholar